CD34 positive progenitors can be cytogenetically normal in patients with myelodysplastic syndromes (MDS).

被引：0
|
作者：
Abruzzese, E
Radford, JE
Pettenati, MJ
Rao, PN
Hurd, DD
Rainer, RO
Powell, BL
Torti, FM
机构：
[1] WAKE FOREST UNIV,CTR COMPREHENS CANC,WINSTON SALEM,NC 27109
[2] UNIV ROMA TOR VERGATA,CATTEDRA EMATOL,ROME,ITALY
来源：
BLOOD | 1996年 / 88卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1906 / 1906
页数：1
相关论文
共 50 条
  • [41] EXPRESSION OF CD34 AND P-GLYCOPROTEIN - PROGNOSTIC-SIGNIFICANCE IN PRIMARY MYELODYSPLASTIC SYNDROMES
    RUNDE, V
    GERMING, U
    AUL, C
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1995, 7 (04) : 901 - 905
  • [42] Quantitative analysis of bone marrow CD34 cells in aplastic anemia and hypoplastic myelodysplastic syndromes
    W H Matsui
    R A Brodsky
    B D Smith
    M J Borowitz
    R J Jones
    Leukemia, 2006, 20 : 458 - 462
  • [43] Differential expression of CD13 in bone marrow compartments of CD34 cells between different groups of patients with myelodysplastic syndromes
    Matarraz, S.
    Lopez, A.
    Salvador, C.
    Fernandez-Mosteirin, N.
    Giralt, M.
    Orfao, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 373 - 373
  • [44] Assessing the Prognosis of Patients with Myelodysplastic Syndromes (MDS)
    Kasprzak, Annika
    Nachtkamp, Kathrin
    Gattermann, Norbert
    Germing, Ulrich
    CANCERS, 2022, 14 (08)
  • [45] INTENSIVE CHEMOTHERAPY FOR PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS)
    BERNSTEIN, SH
    BRUNETTO, VL
    DAVEY, FR
    MAYER, RJ
    WURSTERHILL, D
    SCHIFFER, CA
    BLOOMFIELD, CD
    BLOOD, 1993, 82 (10) : A196 - A196
  • [46] Hypoplastic myelodysplastic syndromes can be distinguished from acquired aplastic anemia by CD34 and PCNA immunostaining of bone marrow biopsy specimens
    Orazi, A
    Albitar, M
    Heerema, NA
    Haskins, S
    Neiman, RS
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1997, 107 (03) : 268 - 274
  • [47] Assessment Of EZH2 Expression In CD34+Bone Marrow Progenitor Cells Of Patients Of Myelodysplastic Syndromes (MDS)
    Wei, Yue
    Zheng, Hong
    Yang, Hui
    Chen, Rui
    Wang, Hui
    Wane, Xia
    Garcia-Manero, Guillermo
    BLOOD, 2013, 122 (21)
  • [48] Abnormalities of myeloblast CD34 and (or) CD117 expression are highly informative in flow cytometric assessment of myelodysplastic syndromes
    Pirruccello, SJ
    Young, KH
    Aoun, P
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2005, 68B (01) : 65 - 66
  • [49] CD34 IMMUNOHISTOCHEMISTRY OF BONE-MARROW BIOPSIES - PROGNOSTIC-SIGNIFICANCE IN PRIMARY MYELODYSPLASTIC SYNDROMES
    SOLIGO, DA
    ORIANI, A
    ANNALORO, C
    CORTELEZZI, A
    CALORI, R
    POZZOLI, E
    NOSELLA, D
    ORAZI, A
    DELILIERS, GL
    AMERICAN JOURNAL OF HEMATOLOGY, 1994, 46 (01) : 9 - 17
  • [50] Lecam1/ICAM ratio identifies a distinct pattern on normal and myelodysplastic syndromes (MDS) bone marrow CD34+cells.
    Buccisano, F
    Venditti, A
    Del Poeta, G
    Maurillo, L
    Abruzzese, E
    Tamburini, A
    Del Principe, MI
    Amadori, S
    BLOOD, 2000, 96 (11) : 833A - 833A
12345